Search clinical trials for: Relapsed/Refractory High-Risk Neuroblastoma
Total 1090 results
-
Memorial Sloan Kettering Cancer CenterNo longer available
-
Dana-Farber Cancer InstituteNot yet recruitingNeuroblastoma | Pediatric Cancer | High-risk Neuroblastoma | Financial Stress | Disparities | PovertyUnited States
-
Jagiellonian UniversityRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk Neuroblastoma | Patient With Insufficient Response ChemoimmunotherapyFrance, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruitingNeuroblastoma | High-RiskUnited States
-
Baylor College of MedicineSt. Jude Children's Research Hospital; The Methodist Hospital Research Institute and other collaboratorsCompletedNeuroblastomaUnited States
-
Baylor College of MedicineCompleted
-
BayerCompletedBlood Loss, SurgicalUnited States, Canada, Puerto Rico
-
Tanta UniversityRecruitingPassive Leg Raising | High-Risk Surgical Patients | Trendelenburg ManeuverEgypt
-
Peter MacCallum Cancer Centre, AustraliaAbbVieNot yet recruitingRelapsed/Refractory Large B-cell LymphomaAustralia
-
Merck Sharp & Dohme LLCNot yet recruitingBurkitt Lymphoma | Ewing Sarcoma | Neuroblastoma | Diffuse Large B-cell Lymphoma | B-cell Acute Lymphoblastic Leukemia
-
Arvinas Inc.RecruitingRelapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) | Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)United States, Spain
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd; Suzhou Hongci Hematology...RecruitingLymphoma, B-Cell | Autologous Stem Cell TransplantationChina
-
LLS PedAL Initiative, LLCKura OncologyNot yet recruitingRelapsed/Refractory KMT2A-r Acute Leukemia | Relapsed/Refractory NUP98-r Acute Leukemia | Relapsed/Refractory NPM1-m Acute Leukemia
-
Xijing HospitalRecruitingHigh-Risk Percutaneous Coronary Intervention (High-risk PCI) | Left Ventricular Assist DevicesChina
-
Peking University People's HospitalNot yet recruitingRelapsed/Refractory Multiple MyelomaChina
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma
-
European Institute of OncologyRecruitingAnal Cancer | High-Risk Cancer | Anal Intraepithelial Neoplasia 2 | Anal Intraepithelial Neoplasia 1Italy
-
Children's Hospital of Soochow UniversityRecruitingAML, Childhood | C-KIT Mutation | Refractory AML | Relapse/Recurrence | Core Binding Factor Acute Myeloid LeukemiaChina
-
Peking University Cancer Hospital & InstituteRecruitingRelapsed/Refractory B-cell Non-Hodgkin LymphomaChina
-
M.D. Anderson Cancer CenterElevar TherapeuticsNot yet recruitingMetastatic Olfactory Neuroblastoma | Recurrent Olfactory NeuroblastomaUnited States
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Federal Research Institute of Pediatric Hematology...University Medical Center, KazakhstanRecruitingNeuroblastoma | Ganglioneuroblastoma | GanglioneuromaRussian Federation
-
Regeneron PharmaceuticalsNot yet recruitingRelapsed/Refractory Systemic Light Chain Amyloidosis
-
M.D. Anderson Cancer CenterNot yet recruitingB-cell Acute Lymphocytic Leukemia | Relapsed/RefractoryUnited States
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)France, Denmark, Israel, Spain, Italy, Germany, Sweden
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Second Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
Jiangxi Provincial Cancer HospitalRecruitingNasopharyngeal Carcinoma | Maintenance Therapy | High-Risk CancerChina
-
University Hospital, Strasbourg, FranceRecruiting
-
Hongmeng YuRecruitingOlfactory NeuroblastomaChina
-
Atara BiotherapeuticsRecruitingHigh-grade B-cell Lymphoma | MCL | Diffuse Large B-cell Lymphoma (DLBCL) | Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | DLBCL/High-grade B-cell Lymphoma With MYC and BCL2 Rearrangements | Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma | LBCL With IRF4 Rearrangement | High-grade B-cell... and other conditionsUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
Innervate Radiopharmaceuticals LLC (Formerly: Illumina...Albert Einstein College of MedicineNot yet recruitingNeuroblastoma | Pheochromocytoma | ParagangliomaUnited States
-
Regeneron PharmaceuticalsRecruitingB-Cell Non-Hodgkin Lymphoma (B-NHL)Taiwan, Spain, Korea, Republic of, Thailand, Italy, Malaysia, Turkey, Australia
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaRecruitingRelapsed/Refractory Large Granular T Lymphocytic LeukemiaChina
-
GlaxoSmithKlineKwame Nkrumah University of Science and Technology; European & Developing Countries... and other collaboratorsRecruiting
-
University of Maryland, BaltimoreJanssen Scientific Affairs, LLCRecruitingProstate Cancer | Oligometastatic DiseaseUnited States
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
University of California, San FranciscoJazz PharmaceuticalsNot yet recruitingThrombotic Microangiopathies | Neuroblastoma | High-risk Neuroblastoma | Transplant-Associated Thrombotic MicroangiopathyUnited States
-
National Cancer Institute (NCI)RecruitingLocally Advanced Chondrosarcoma | Metastatic Chondrosarcoma | Metastatic Sinonasal Adenocarcinoma | Locally Advanced Sinonasal Adenocarcinoma | Metastatic Large-cell Neuroendocrine Carcinoma | Locally Advanced Large-cell Neuroendocrine Carcinoma | Metastatic Olfactory Neuroblastoma | Locally Advanced... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingNeuroblastoma | GanglioneuroblastomaUnited States
-
BeBetter Med IncRecruitingRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
Shanghai Ming Ju Biotechnology Co., Ltd.RecruitingLymphoma, Non-Hodgkin | Diffuse Large B Cell LymphomaChina
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Italy, Poland, United States, Thailand, United Kingdom, Belgium, Turkey, Czechia
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRelapsed/Refractory PTCLT With at Least One Line of Prior Systemic TherapyChina
-
OncotherapeuticsNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Memorial Sloan Kettering Cancer CenterRecruitingSolid Tumor | Neuroblastoma | Solid Tumor, Adult | Primary Brain Tumor | Solid Carcinoma | Low-grade Glioma | Central Nervous System Tumor | Refractory Cancer | CNS Tumor, Adult | CNS Tumors | NF1 | Plexiform Neurofibroma | CNS Tumor, Childhood | Optic Pathway Gliomas | MAP Kinase Family Gene MutationUnited States
-
Bristol-Myers SquibbRecruitingRelapsed/Refractory Non-Hodgkin LymphomaUnited States, Spain, France, Netherlands, Switzerland
-
Chinese PLA General HospitalThe General Hospital of Western Theater Command; First Hospital of China Medical... and other collaboratorsRecruitingRelapsed/Refractory Acute Myeloid LeukemiaChina
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingRelapsed/Refractory Marginal Zone LymphomaChina